Iranian Journal of Psychiatry and Behavioral Sciences

Published by: Shiraz University of Medical Sciences

Transition to and Away from Injecting Drug Use among Young Drug Users in Tehran, Iran: A Qualitative Study

Afarin Rahimi-Movaghar 1 , Alireza Noroozi 1 , 2 , Kimberly Page 3 , Minoo Mohraz 4 , William McFarland 3 , Hossein Malekafzali 5 and Mohsen Malekinejad 6 , *
Authors Information
1 Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences (TUMS), Tehran, IR Iran
2 Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine (SATiM), Tehran University of Medical Sciences, Tehran, IR Iran
3 Department of Epidemiology and Biostatistics, Division of Preventive Medicine and Public Health and Global Health Sciences, University of California San Francisco, San Francisco, USA
4 Iranian Research Center for HIV/AIDS (IRCHA), Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, IR Iran
5 Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran
6 Institute for Health Policy Studies, University of California San Francisco, 3333 California Street, Suite 265, San Francisco, CA 94118, USA
Article information
  • Iranian Journal of Psychiatry and Behavioral Sciences: March 2017, 11 (1); e4561
  • Published Online: December 28, 2016
  • Article Type: Original Article
  • Received: November 1, 2015
  • Revised: July 31, 2016
  • Accepted: December 25, 2016
  • DOI: 10.5812/ijpbs.4561

To Cite: Rahimi-Movaghar A, Noroozi A, Page K, Mohraz M, McFarland W, et al. Transition to and Away from Injecting Drug Use among Young Drug Users in Tehran, Iran: A Qualitative Study, Iran J Psychiatry Behav Sci. 2017 ;11(1):e4561. doi: 10.5812/ijpbs.4561.

Copyright © 2016, Mazandaran University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Materials and Methods
3. Results
4. Discussion
5. Conclusion
  • 1. World Drug Report. 2011;
  • 2. Sharifi V, Amin-Esmaeili M, Hajebi A, Motevalian A, Radgoodarzi R, Hefazi M, et al. Twelve-month prevalence and correlates of psychiatric disorders in Iran: the Iranian Mental Health Survey, 2011. Arch Iran Med. 2015; 18(2): 76-84[PubMed]
  • 3. Amin-Esmaeili M, Rahimi-Movaghar A, Sharifi V, Hajebi A, Radgoodarzi R, Mojtabai R, et al. Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the Iranian Mental Health Survey. Addiction. 2016; 111(10): 1836-47[DOI][PubMed]
  • 4. Rahimi-Movaghar A, Amin-Esmaeili M, Haghdoost AA, Sadeghirad B, Mohraz M. HIV prevalence amongst injecting drug users in Iran: a systematic review of studies conducted during the decade 1998-2007. Int J Drug Policy. 2012; 23(4): 271-8[DOI][PubMed]
  • 5. Iran, Progress Report on Monitoring of the United Nations General Assembly Special Session on HIV/AIDS. [in Persian] 2012;
  • 6. Amin-Esmaeili M, Rahimi-Movaghar A, Haghdoost AA, Mohraz M. Evidence of HIV epidemics among non-injecting drug users in Iran: a systematic review. Addiction. 2012; 107(11): 1929-38[DOI][PubMed]
  • 7. Amin-Esmaeili M, Rahimi-Movaghar A, Razaghi EM, Baghestani AR, Jafari S. Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran. Hepat Mon. 2012; 12(1): 23-31[DOI][PubMed]
  • 8. SeyedAlinaghi SA, Kheirandish P, Karami N, Salem S, Shirzad H, Jahani MR, et al. High prevalence of chronic hepatitis B infection among injection drug users in Iran: the need to increase vaccination of adults at risk. Acta Med Iran. 2010; 48(1): 58-60[PubMed]
  • 9. Tavakkoli H, Mir-Nasseri MM, Poustchi H, Afshar P, Motalebi MN, Mohammadkhani A, et al. Prevalence and risk factors of hepatitis B infection in injection drug users, Tehran (2001-2002). Hepat Mon. 2008; 8(1): 29-33
  • 10. Zobeiri M, Adibi P, Alavian SM. Intravenous drug use and hepatitis C virus in iran. Hepat Mon. 2012; 12(1): 9-10[DOI][PubMed]
  • 11. Young AM, Havens JR. Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis. Addiction. 2012; 107(3): 587-96[DOI][PubMed]
  • 12. Miller CL, Pearce ME, Moniruzzaman A, Thomas V, Christian W, Schechter MT, et al. The Cedar Project: risk factors for transition to injection drug use among young, urban Aboriginal people. CMAJ. 2011; 183(10): 1147-54[DOI][PubMed]
  • 13. Des Jarlais DC, Arasteh K, Perlis T, Hagan H, Heckathorn DD, McKnight C, et al. The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City. Addiction. 2007; 102(5): 778-85[DOI][PubMed]
  • 14. Sanchez J, Chitwood DD, Koo DJ. Risk factors associated with the transition from heroin sniffing to heroin injection: a street addict role perspective. J Urban Health. 2006; 83(5): 896-910[DOI][PubMed]
  • 15. Rahimi-Movaghar A, Amin-Esmaeili M, Aaraj E, Hermez J. Assessment of situation and response to drug use and its harms in the Middle East and North Africa, 2012. 2013;
  • 16. Malekinejad M, Vazirian M. Transition to injection amongst opioid users in Iran: implications for harm reduction. Int J Drug Policy. 2012; 23(4): 333-7[DOI][PubMed]
  • 17. Narenjiha H, Rafiei H, Baghestani AR, Nouri R, Ghafouri B, Soleimaninia L. Rapid situation assessment of drug abuse in Iran. 2007;
  • 18. Neaigus A, Miller M, Friedman SR, Hagen DL, Sifaneck SJ, Ildefonso G, et al. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction. 2001; 96(6): 847-60[DOI][PubMed]
  • 19. Roy E, Nonn E, Haley N. Transition to injection drug use among street youth--a qualitative analysis. Drug Alcohol Depend. 2008; 94(1-3): 19-29[DOI][PubMed]
  • 20. Neaigus A, Gyarmathy VA, Miller M, Frajzyngier VM, Friedman SR, Des Jarlais DC. Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility. J Acquir Immune Defic Syndr. 2006; 41(4): 493-503[DOI][PubMed]
  • 21. Vlahov D, Fuller CM, Ompad DC, Galea S, Des Jarlais DC. Updating the infection risk reduction hierarchy: preventing transition into injection. J Urban Health. 2004; 81(1): 14-9[DOI][PubMed]
  • 22. Razani N, Mohraz M, Kheirandish P, Malekinejad M, Malekafzali H, Mokri A, et al. HIV risk behavior among injection drug users in Tehran, Iran. Addiction. 2007; 102(9): 1472-82[DOI][PubMed]
  • 23. Bravo MJ, Barrio G, de la Fuente L, Royuela L, Domingo L, Silva T. Reasons for selecting an initial route of heroin administration and for subsequent transitions during a severe HIV epidemic. Addiction. 2003; 98(6): 749-60[PubMed]
  • 24. Roy E, Haley N, Leclerc P, Cedras L, Blais L, Boivin JF. Drug injection among street youths in Montreal: predictors of initiation. J Urban Health. 2003; 80(1): 92-105[DOI][PubMed]
  • 25. Darke S, Cohen J, Ross J, Hando J, Hall W. Transitions between routes of administration of regular amphetamine users. Addiction. 1994; 89(9): 1077-83[PubMed]
  • 26. Draus PJ, Carlson RG. Needles in the haystacks: the social context of initiation to heroin injection in rural Ohio. Subst Use Misuse. 2006; 41(8): 1111-24[DOI][PubMed]
  • 27. Dunn M, Degenhardt L, Bruno R. Transition to and from injecting drug use among regular ecstasy users. Addict Behav. 2010; 35(10): 909-12[DOI][PubMed]
  • 28. Abelson J, Treloar C, Crawford J, Kippax S, van Beek I, Howard J. Some characteristics of early-onset injection drug users prior to and at the time of their first injection. Addiction. 2006; 101(4): 548-55[DOI][PubMed]
  • 29. Koram N, Liu H, Li J, Li J, Luo J, Nield J. Role of social network dimensions in the transition to injection drug use: actions speak louder than words. AIDS Behav. 2011; 15(7): 1579-88[DOI][PubMed]
  • 30. Khobzi N, Strike C, Cavalieri W, Bright R, Myers T, Calzavara L, et al. A qualitative study on the initiation into injection drug use: Necessary and background processes. Addict Res Theory. 2009; 17(5): 546-59[DOI]
  • 31. Jafari S, Rahimi-Movaghar A, Craib KJP, Baharlou S, Mathias R. A follow-up study of drug users in Southern Iran. Addict Res Theory. 2009; 18(1): 59-70[DOI]
  • 32. De Kort G, Batra S, Pasaribu R, Vazirian M, Ul-Hassan S. Young people and drugs - Towards a comprehensive health promotion policy, final report. 2005;
  • 33. de la Fuente L, Barrio G, Royuela L, Bravo MJ. The transition from injecting to smoking heroin in three Spanish cities. The Spanish Group for the Study of the Route of Heroin Administration. Addiction. 1997; 92(12): 1749-63[PubMed]
  • 34. Mehta SH, Sudarshi D, Srikrishnan AK, Celentano DD, Vasudevan CK, Anand S, et al. Factors associated with injection cessation, relapse and initiation in a community-based cohort of injection drug users in Chennai, India. Addict Res Theory. 2012; 107: 349-58
  • 35. van Ameijden EJ, Coutinho RA. Large decline in injecting drug use in Amsterdam, 1986-1998: explanatory mechanisms and determinants of injecting transitions. J Epidemiol Community Health. 2001; 55(5): 356-63[PubMed]
  • 36. Fuller CM, Vlahov D, Ompad DC, Shah N, Arria A, Strathdee SA. High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug Alcohol Depend. 2002; 66(2): 189-98[PubMed]
  • 37. Hunt N, Griffiths P, outhwell M, Stillwell J, Strang J. Preventing and curtailing injecting drug use: A review of opportunities for developing and delivering'route transition interventions'. Drug Alcohol Rev. 1999; 18(4): 441-51
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments